Becton, Dickinson and Company vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
BDX
Consensus analyst target of $191.46 is 28% above current price.
⚠ analyst sentiment is cautious.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $191.46 (+28.2%)
13 analysts
BUY
Target $252.42 (+11.1%)
24 analysts
Fundamentals
BDX
JNJ
24.4×
Trailing P/E
26.3×
11.1×
Forward P/E
17.9×
8.0%
Profit Margin
21.8%
46.8%
Gross Margin
68.0%
7.0%
ROE
26.4%
1.6%
Revenue Growth
9.9%
28.6%
Earnings Growth
-52.9%
0.35
Beta
0.33
—
Price / Book
—
$42.5B
Market Cap
$546.9B
$128 – $187
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →